[
    "{\"step_by_step_thinking\": \"Verubecestat is a BACE1 inhibitor that was developed to reduce amyloid-beta levels in the brain and potentially treat Alzheimer's disease. However, multiple clinical trials, including phase III trials, have shown that Verubecestat did not improve cognitive or functional decline in patients with mild-to-moderate or prodromal Alzheimer's disease. In fact, Verubecestat was associated with treatment-related adverse events. Therefore, based on the available evidence, the answer is B. no, Verubecestat is not effective for Alzheimer's Disease.\", \"answer_choice\": \"B\"}"
]